314 related articles for article (PubMed ID: 29522204)
41. Corticosteroids in Myositis and Scleroderma.
Postolova A; Chen JK; Chung L
Rheum Dis Clin North Am; 2016 Feb; 42(1):103-18, ix. PubMed ID: 26611554
[TBL] [Abstract][Full Text] [Related]
42. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.
Brady S; Squier W; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1240-6. PubMed ID: 23864699
[TBL] [Abstract][Full Text] [Related]
43. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
Papadimas GK; Kokkinis C; Xirou S; Chrysanthou M; Kararizou E; Papadopoulos C
Rheumatol Int; 2019 Aug; 39(8):1459-1466. PubMed ID: 31055642
[TBL] [Abstract][Full Text] [Related]
44. [Myositides].
Bornemann A; Heitmann S; Lindner A
Pathologe; 2009 Sep; 30(5):352-6. PubMed ID: 19618187
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
[TBL] [Abstract][Full Text] [Related]
46. Idiopathic inflammatory myopathies.
Dimachkie MM
J Neuroimmunol; 2011 Feb; 231(1-2):32-42. PubMed ID: 21093064
[TBL] [Abstract][Full Text] [Related]
47. Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features.
Stenzel W; Goebel HH; Aronica E
Neuropathol Appl Neurobiol; 2012 Dec; 38(7):632-46. PubMed ID: 22989019
[TBL] [Abstract][Full Text] [Related]
48. Edematous myositis: a clinical presentation first suggesting dermatomyositis diagnosis.
Duchesne M; Leonard-Louis S; Landon-Cardinal O; Anquetil C; Mariampillai K; Monzani Q; Benveniste O; Allenbach Y
Brain Pathol; 2020 Sep; 30(5):867-876. PubMed ID: 32323412
[TBL] [Abstract][Full Text] [Related]
49. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Gulati S; Handa R
Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129
[TBL] [Abstract][Full Text] [Related]
50. [Idiopathic myositis].
Burgunder JM
Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
[TBL] [Abstract][Full Text] [Related]
51. TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies.
Kuiperij HB; Abdo WF; van Engelen BG; Schelhaas HJ; Verbeek MM
Acta Neuropathol; 2010 Dec; 120(6):825-6. PubMed ID: 21046407
[No Abstract] [Full Text] [Related]
52. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.
Stenzel W; Preuße C; Allenbach Y; Pehl D; Junckerstorff R; Heppner FL; Nolte K; Aronica E; Kana V; Rushing E; Schneider U; Claeys KG; Benveniste O; Weis J; Goebel HH
Neurology; 2015 Mar; 84(13):1346-54. PubMed ID: 25746564
[TBL] [Abstract][Full Text] [Related]
53. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
54. Distribution of the NF-kappaB complex in the inflammatory exudates characterizing the idiopathic inflammatory myopathies.
Creus KK; De Paepe B; Werbrouck BF; Vervaet V; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():370-7. PubMed ID: 19758175
[TBL] [Abstract][Full Text] [Related]
55. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
Hiniker A; Daniels BH; Margeta M
J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
[TBL] [Abstract][Full Text] [Related]
56. Major histocompatibility complex class I expression can be used as a diagnostic tool to differentiate idiopathic inflammatory myopathies from dystrophies.
Sundaram C; Uppin MS; Meena AK
Neurol India; 2008; 56(3):363-7. PubMed ID: 18974565
[TBL] [Abstract][Full Text] [Related]
57. Diagnosis and classification of idiopathic inflammatory myopathies.
Lundberg IE; Miller FW; Tjärnlund A; Bottai M
J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
[TBL] [Abstract][Full Text] [Related]
58. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
Raju R; Dalakas MC
Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
[TBL] [Abstract][Full Text] [Related]
59. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study.
Yongchairat K; Tanboon J; Waisayarat J; Narongroeknawin P; Chevaisrakul P; Dejthevaporn C; Katchamart W
Clin Rheumatol; 2019 Dec; 38(12):3459-3469. PubMed ID: 31446540
[TBL] [Abstract][Full Text] [Related]
60. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
de Padilla CM; Reed AM
Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]